Filing Flows › Rani Therapeutics Holdings (RANI) › Recalls, complaints & regulation

Rani Therapeutics Holdings (RANI): clinical trials

Rani Therapeutics Holdings (RANI) beyond its filings: 1 active clinical trial.

Rani Therapeutics Holdings' latest quarter

Rani Therapeutics Holdings, Q2 2026: revenue $1.7M, operating margin -516.9%, net loss $8.4M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Rani Therapeutics Holdings have?

1 active study on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.